SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Advisory Committee Unanimously Recommends Approval of Centocor, Inc.'s Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis